Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling.

Source:http://linkedlifedata.com/resource/pubmed/id/14657335

Proc. Natl. Acad. Sci. U.S.A. 2003 Dec 9 100 25 15113-8

Download in:

View as

Triples

General Info

PMID
14657335